Category: Regulations
-
FDA Clears First Mobile App for Substance Abuse
A smartphone app designed to help treat substance abuse disorders received approval from the U.S. Food and Drug Administration.
-
Trial Shows Antibody Effective Against Asthma
Results from a large-scale clinical trial show a synthetic antibody, when added to standard treatments, reduces asthma attacks and improves lung functioning.
-
Risks of E-Cigarette Use, Ingredients Highlighted
Several sessions at a scientific meeting on respiratory diseases report on effects of electronic cigarettes on people’s health, including those who also smoke conventional cigarettes.
-
Engineered T-Cell Trials Stopped after Patient Death
The Food and Drug Administration stopped two clinical trials testing genetically engineered T-cells from the immune system to treat leukemia, after a participant in one trial died.
-
Trial Testing Nicotine Patch for Lung Inflammation
A clinical trial is underway testing a nicotine patch worn to help stop smoking as a treatment for a chronic inflammatory disease affecting the lungs.
-
Infographic – Vaccinations Changed the World
This chart, courtesy of Der Spiegel and Statista, shows how the incidence of several diseases has been reduced in the U.S. since the introduction of vaccines.
-
Telemedicine Shown Feasible for Parkinson’s Care
Findings from a one-year clinical trial show individuals in the U.S. with Parkinson’s disease can receive quality care through telemedicine comparable to persons with the disorder receiving the usual care from neurologists alone.
-
Tracking Algorithms Devised to ID Human Traffickers
Computer scientists developed techniques that help identify the people placing sexual service advertisements by tracing the bitcoin payments for those ads.
-
Trial Underway Testing New ALS Treatment
Patients in a clinical trial testing a treatment for amyotrophic lateral sclerosis, or ALS, began receiving their first doses administered by the study team.
-
Trial to Test Inhaled Insulin, App for Diabetes Mgmt
A clinical trial is planned to test the benefits of managing type 2 diabetes with an inhaled formulation of insulin and a smartphone app.